A method and kit for simultaneously measuring folic acid and homocysteine ​​content in blood

By employing high-performance liquid chromatography-triple quadrupole mass spectrometry (HPLC-MS/MS) and specific extraction reagents, the matrix interference and stability issues in the detection of folic acid and homocysteine ​​in whole blood samples have been resolved, enabling rapid and accurate simultaneous determination. This method is suitable for health monitoring and disease risk assessment of large populations.

CN115436540BActive Publication Date: 2024-11-26BY HEALTH CO LTD
View PDF 13 Cites 0 Cited by

Patent Information

Application Number
CN202211176098.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-09-26
Publication Date
2024-11-26
Estimated Expiration
2042-09-26

AI Technical Summary

Technical Problem

Existing technologies for detecting human folic acid and homocysteine ​​suffer from problems such as cumbersome sample processing, long detection time, high cost, severe matrix interference, and poor Hcy stability, making them unsuitable for disease diagnosis and health monitoring in large populations.

Method used

High-performance liquid chromatography-triple quadrupole mass spectrometry (HPLC-MS/MS) was employed, combined with extraction reagents of ascorbic acid, citric acid, ammonia, and dithiothreitol, and centrifugation filtration and gradient elution techniques were used to achieve rapid and accurate quantification of folic acid and homocysteine ​​in whole blood samples.

Benefits of technology

The pretreatment steps have been simplified, enabling the simultaneous determination of folic acid and homocysteine. The detection method is simple, rapid, accurate, and low-cost, making it suitable for health monitoring and disease risk assessment of large populations.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115436540B_ABST
    Figure CN115436540B_ABST
Patent Text Reader

Abstract

The present invention provides a kit for simultaneously measuring the content of folic acid and homocysteine ​​in blood, comprising an extraction reagent; the extraction reagent comprises: ascorbic acid, citric acid, ammonia water, and dithiothreitol. Compared with the prior art, the kit of the present invention is used to measure the content of folic acid and Hcy, which saves cumbersome pre-detection treatment and can measure simultaneously, that is, it can achieve accurate determination of folic acid and homocysteine ​​in blood. The detection method is simple, rapid, accurate, and low in detection cost.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of blood detection, and in particular relates to a method and a detection system for simultaneously determining the contents of folic acid and homocysteine ​​in dried blood spots. Background Art

[0002] Homocysteine ​​(Hcy) is a sulfur-containing amino acid and an intermediate product of methionine metabolism. With the establishment of the metabolic pathway of Hcy in the body, domestic and foreign scholars have conducted a lot of research on the relationship between high Hcy and various diseases such as coronary heart disease, peripheral vascular disease and cerebrovascular disease. It is believed that increased blood Hcy levels can cause and aggravate heart failure, and its mechanism of action is unrelated to coronary heart disease. It is a direct damage to the myocardium and an independent risk factor for causing and aggravating heart failure. At the same time, Hcy is related to various diseases such as neural tube defects, kidney disease, and Alzheimer's disease. About 75% of Hcy in plasma is bound to albumin and is in the bound state. Some exist in the form of disulfide-bonded Hcy-Hcy and Hcy-cysteine ​​compounds, and only 1%-2% exists in the plasma in the reduced state.

[0003] Folic acid is closely related to the metabolic process of Hcy. Both domestic and foreign studies have shown that folic acid supplementation can reduce blood Hcy levels. Folic acid, also known as pteroylglutamic acid, is a water-soluble vitamin essential for the synthesis of nucleic acids, thymidylic acid, neurotransmitters, phospholipids and hormones. It is a carrier of one-carbon units in the body and participates in various metabolic reactions. It is a substance necessary for cell growth and reproduction. It can be used clinically to prevent neural tube defects, treat chronic atrophic gastritis, inhibit bronchial squamous transformation, and prevent and treat coronary artery sclerosis, myocardial damage and myocardial infarction caused by hyperhomocysteinemia. Studies have shown that folic acid can also inhibit the expression of oncogenes in tumor cells, thereby blocking the progression of malignant tumors, but some studies believe that excessive intake of folic acid may increase the risk of breast cancer.

[0004] At present, the commonly used method for detecting folic acid and Hcy in the human body is to use plasma detection. Plasma samples need to be transported in a cold chain, which is very inconvenient on the way. At present, the detection of folic acid and Hcy mainly includes microbiological assay, radioimmunoassay, chromatography, liquid chromatography-mass spectrometry, etc. These methods have certain limitations in terms of specificity and sensitivity, and the sample consumption is relatively large. According to the existing technology, whole blood samples need to be processed into serum to complete the detection, otherwise the detection of folic acid will be greatly interfered, the pre-treatment steps of the detection method are relatively cumbersome, the detection time is long, the detection cost is high, and it is difficult to apply to the disease diagnosis and health monitoring needs of a large sample population.

[0005] For whole blood samples, there are great technical difficulties in detecting folic acid and Hcy at the same time. The matrix of whole blood samples is more complex than that of plasma and serum, and the matrix interference is serious. Folic acid cannot be accurately quantified. Folic acid needs to go through a purification step, and the stability of Hcy in the extraction reagent is very poor. In a short period of time, most of the Hcy has been degraded, which seriously affects the accuracy of the test results. It is necessary to develop stabilizers of appropriate concentrations. Only by overcoming these two major difficulties can the content of folic acid and Hcy in whole blood samples be accurately detected. Summary of the invention

[0006] The present invention is based on dried blood spot technology and uses high performance liquid chromatography-triple quadrupole mass spectrometry (HPLC-MS / MS) to establish a novel method for simultaneously determining the content of folic acid and Hcy with high sensitivity, good reproducibility and fast analysis speed. Therefore, the rapid and accurate quantification of the content of folic acid and Hcy in whole blood can provide a basis for the prevention, diagnosis and treatment of diseases in a large sample of people.

[0007] In one aspect, the present invention provides an extraction reagent for simultaneously extracting folic acid and homocysteine ​​from blood.

[0008] The extraction reagent comprises: ascorbic acid, citric acid, ammonia water and dithiothreitol.

[0009] The preparation method of the extraction reagent is as follows: weigh ascorbic acid and citric acid, add water and ammonia water, dissolve and mix well, then dilute, add dithiothreitol, dissolve and mix well, and obtain the extraction reagent.

[0010] Preferably, the preparation method of the extraction reagent is: weigh 10 mg of ascorbic acid, 10 mg of citric acid, add 9.5 mL of water and 0.5 mL of ammonia water, dissolve and mix, then transfer 0.22 mL, add 4.78 mL of water, add 215 mg of dithiothreitol, dissolve and mix to obtain the extraction reagent.

[0011] On the other hand, the present invention provides a use of an extraction reagent in preparing an extraction kit for simultaneously extracting folic acid and homocysteine ​​in blood.

[0012] The extraction reagent comprises: ascorbic acid, citric acid, ammonia water and dithiothreitol.

[0013] The preparation method of the extraction reagent is as follows: weigh ascorbic acid and citric acid, add water and ammonia water, dissolve and mix well, then dilute, add dithiothreitol, dissolve and mix well, and obtain the extraction reagent.

[0014] Preferably, the preparation method of the extraction reagent is: weigh 10 mg of ascorbic acid, 10 mg of citric acid, add 9.5 mL of water and 0.5 mL of ammonia water, dissolve and mix, then transfer 0.22 mL, add 4.78 mL of water, add 215 mg of dithiothreitol, dissolve and mix to obtain the extraction reagent.

[0015] In yet another aspect, the present invention provides an extraction kit for simultaneously extracting folic acid and homocysteine ​​from a blood sample.

[0016] The extraction kit comprises an extraction reagent; the extraction reagent comprises: ascorbic acid, citric acid, ammonia water and dithiothreitol.

[0017] The preparation method of the extraction reagent is as follows: weigh ascorbic acid and citric acid, add water and ammonia water, dissolve and mix well, then dilute, add dithiothreitol, dissolve and mix well, and obtain the extraction reagent.

[0018] Preferably, the preparation method of the extraction reagent is: weigh 10 mg of ascorbic acid, 10 mg of citric acid, add 9.5 mL of water and 0.5 mL of ammonia water, dissolve and mix, then transfer 0.22 mL, add 4.78 mL of water, add 215 mg of dithiothreitol, dissolve and mix to obtain the extraction reagent.

[0019] In yet another aspect, the present invention provides a method for simultaneously extracting folic acid and homocysteine ​​from a blood sample.

[0020] The blood sample is a dried blood spot blood sample.

[0021] The method includes: placing the dried blood spot blood sample into a 30kDa centrifugal filter device, adding an extraction reagent, vortexing for about 30 seconds, standing in the dark for 15 minutes, then vortexing for about 30 seconds, and then gradually increasing the speed to 1000r / min, 2000r / min, 4000r / min, and 10000r / min, and centrifuging for 2 minutes at each speed to obtain the extract.

[0022] The extraction reagent comprises: ascorbic acid, citric acid, ammonia water and dithiothreitol.

[0023] The preparation method of the extraction reagent is as follows: weigh ascorbic acid and citric acid, add water and ammonia water, dissolve and mix well, then dilute, add dithiothreitol, dissolve and mix well, and obtain the extraction reagent.

[0024] Preferably, the preparation method of the extraction reagent is: weigh 10 mg of ascorbic acid, 10 mg of citric acid, add 9.5 mL of water and 0.5 mL of ammonia water, dissolve and mix, then transfer 0.22 mL, add 4.78 mL of water, add 215 mg of dithiothreitol, dissolve and mix to obtain the extraction reagent.

[0025] In yet another aspect, the present invention provides use of the aforementioned extraction reagent in preparing a detection kit for simultaneously determining folic acid and homocysteine ​​in blood.

[0026] The kit comprises the aforementioned extraction reagent.

[0027] The detection kit also includes an isotope-extracting internal standard reagent.

[0028] The isotope internal standard reagents are homocysteine-D8 isotope internal standard and folic acid- 13 C5, 15 N isotope internal standard.

[0029] The detection kit also includes a high performance liquid chromatography reagent; the high performance liquid chromatography reagent includes a 0.1% formic acid aqueous solution and a 0.1% formic acid acetonitrile solution.

[0030] The liquid phase conditions of the high performance liquid chromatography are as follows: chromatographic column: Waters, HSS T3, 100×2.1 mm, 2.5 μm; column temperature: 40° C.; injection volume: 10 μL; flow rate: 0.25 mL / min; mobile phase: A is 0.1% formic acid aqueous solution, B is 0.1% formic acid acetonitrile solution, gradient elution.

[0031] The kit is a high performance liquid chromatography-mass spectrometry kit.

[0032] The mass spectrometry was performed in MRM mode.

[0033] The kit is used for detecting dried blood spot blood samples.

[0034] In yet another aspect, the present invention provides a detection kit for simultaneously determining the contents of folic acid and homocysteine ​​in a blood sample.

[0035] The kit comprises the aforementioned extraction reagent.

[0036] The detection kit also includes an isotope-extracting internal standard reagent.

[0037] The isotope internal standard reagents are homocysteine-D8 isotope internal standard and folic acid- 13 C5, 15 N isotope internal standard.

[0038] The detection kit also includes a high performance liquid chromatography reagent; the high performance liquid chromatography reagent includes a 0.1% formic acid aqueous solution and a 0.1% formic acid acetonitrile solution.

[0039] The liquid phase conditions of the high performance liquid chromatography are as follows: chromatographic column: Waters, HSS T3, 100×2.1 mm, 2.5 μm; column temperature: 40° C.; injection volume: 10 μL; flow rate: 0.25 mL / min; mobile phase: A is 0.1% formic acid aqueous solution, B is 0.1% formic acid acetonitrile solution, gradient elution.

[0040] The kit is a high performance liquid chromatography-mass spectrometry kit.

[0041] The mass spectrometry was performed in MRM mode.

[0042] The kit is used for detecting dried blood spot blood samples.

[0043] In yet another aspect, the present invention provides a method for simultaneously determining the contents of folic acid and homocysteine ​​in a blood sample.

[0044] The method described can be performed on blood or dried blood spot samples.

[0045] The blood sample needs to be prepared into a dried blood spot sample for detection.

[0046] The test comprises the following steps: placing a dried blood spot blood sample into a 30 kDa centrifugal filter device, adding an extraction reagent, vortexing for extraction for about 30 seconds, standing in the dark for 15 minutes, then vortexing for mixing for about 30 seconds, and then gradually increasing the speed to 1000 r / min, 2000 r / min, 4000 r / min, and 10000 r / min, and centrifuging for 2 minutes at each speed to obtain an extract;

[0047] The extract is analyzed by high performance liquid chromatography-mass spectrometry and quantified by internal standard method;

[0048] The chromatographic conditions of the high performance liquid chromatography in the analysis are as follows: chromatographic column: Waters, HSS T3, 100×2.1 mm, 2.5 μm; column temperature: 40° C.; injection volume: 10 μL; flow rate: 0.25 mL / min; mobile phase: A is 0.1% formic acid aqueous solution, B is 0.1% formic acid acetonitrile solution, gradient elution.

[0049] The mass spectrometry was performed in MRM mode.

[0050] The extraction reagent is the aforementioned extraction reagent.

[0051] The detection of folic acid and homocysteine ​​content can be used to predict the risk of disease, but the prior art does not show that the detection results of the two can be directly used for disease diagnosis. Therefore, the detection method of the present application is suitable for health monitoring and disease risk assessment of a large sample population.

[0052] Beneficial effects of the present invention:

[0053] The kit of the present invention is used to measure the folic acid and Hcy content. Compared with the prior art, the cumbersome pre-test treatment is omitted and the simultaneous determination can be performed, that is, the folic acid and homocysteine ​​in the blood can be accurately determined. The detection method is simple, rapid, accurate and has low detection cost. BRIEF DESCRIPTION OF THE DRAWINGS

[0054] Figure 1This is the chromatogram of the whole blood sample according to the literature method.

[0055] Figure 2 is a chromatogram of a whole blood sample of the present invention.

[0056] Figure 3 This is the blank chromatogram of folic acid.

[0057] Figure 4 This is the blank chromatogram of homocysteine.

[0058] Figure 5 This is the reference chromatogram of folic acid.

[0059] Figure 6 The homocysteine ​​control chromatogram is shown in Figure 2 .

[0060] Figure 7 This is the working curve of folic acid internal standard.

[0061] Figure 8 This is the homocysteine ​​internal standard working curve.

[0062] Fig. 9 It is the detection limit of folic acid in dried blood spots.

[0063] Fig.10 Detection limit of homocysteine ​​in dried blood spots. DETAILED DESCRIPTION

[0064] The present invention will be further described in detail below in conjunction with specific examples. The following examples are not intended to limit the present invention, but are only intended to illustrate the present invention. The experimental methods used in the following examples are generally conventional, unless otherwise specified, and the materials, reagents, etc. used in the following examples are commercially available, unless otherwise specified.

[0065] Example 1 A method for simultaneously determining the content of folic acid and Hcy in blood

[0066] 1. Instrument

[0067] Liquid chromatography-mass spectrometry: LC-30A liquid chromatograph (SHIMADZU, Japan) connected in series with QTRAP 4500 mass spectrometer (AB SCIEX, USA);

[0068] XSE205DU electronic balance (Mettler Toledo, Switzerland).

[0069] 2. Reagents

[0070] Reagents: primary water; acetonitrile (LC-MS); formic acid (LC-MS); aqueous ammonia (20-22%, LC-MS); 1,4-dithiothreitol (HPLC); ascorbic acid (ACS); citric acid (HPLC).

[0071] Reference substance:

[0072]

[0073] Extraction solution: Weigh 10 mg of ascorbic acid and 10 mg of citric acid, add 9.5 mL of water and 0.5 mL of aqueous ammonia, dissolve and mix well, then transfer 0.22 mL, add 4.78 mL of water, add 215 mg of dithiothreitol, dissolve and mix well to obtain the extraction reagent.

[0074] 0.1% formic acid aqueous solution: Add 0.5 mL formic acid to 500 mL water and mix well.

[0075] 0.1% formic acid in acetonitrile solution: Add 0.5 mL formic acid to 500 mL acetonitrile and mix well.

[0076] 3. Analysis methods

[0077] 3.1 Instrument conditions and parameters

[0078] 3.1.1 Liquid phase conditions

[0079] Chromatographic column: Waters, HSS T3, 100×2.1 mm, 2.5 μm;

[0080] Column temperature: 40°C;

[0081] Injection volume: 10 μL;

[0082] Flow rate: 0.25 mL / min;

[0083] Mobile phase: A is 0.1% formic acid aqueous solution, B is 0.1% formic acid acetonitrile solution, gradient elution according to the following table:

[0084]

[0085]

[0086] 3.1.2 Mass spectrometry conditions

[0087] MRM mode:

[0088] CUR CAD IS TEM GS1 GS2 EP CXP 20 Medium 5500 450 50 50 10 10

[0089]

[0090] *: Quantitative ion pair.

[0091] 3.2 Preparation of reference solution

[0092] 3.2.1 Preparation of isotope internal standard solution

[0093] Weigh folic acid- 13 C5, 15 About 1 mg of N isotope internal standard was placed in a 10 mL volumetric flask, a small amount of water and 1 μL of ammonia water were added, ultrasonically dissolved, water was added to the fixed volume, and mixed to obtain folic acid- 13 C5, 15 Stock standard solution of N isotope internal standard (100 μg / mL).

[0094] Weigh about 1 mg of homocysteine-D8 isotope internal standard, place it in an injection vial, add about 10 mg of dithiothreitol, accurately add 1 mL of water, ultrasonically dissolve, and mix to obtain the stock standard solution of homocysteine-D8 isotope internal standard (1 mg / mL).

[0095] Accurately pipette 10 μL of the stock standard solution of folic acid isotope internal standard into a 10 mL volumetric flask, add water to make up the volume, and shake well to obtain folic acid- 13 C5, 15 N isotope internal standard working standard solution (100 ng / mL).

[0096] Accurately pipette 10 μL of the stock standard solution of homocysteine-D8 isotope internal standard into a 5 mL volumetric flask, add about 50 mg of dithiothreitol, add water to dissolve to volume, and shake well to obtain the working standard solution of homocysteine-D8 isotope internal standard (2000 ng / mL).

[0097] Accurately pipette 200 μL of the working standard solution of the folate isotope internal standard, 200 μL of the working standard solution of the homocysteine-D8 isotope internal standard, and 3.60 mL of the extraction solution, and mix them to obtain the extraction solution containing the isotope internal standard.

[0098] 3.2.2 Preparation of standard solution

[0099] Accurately weigh 10.86 mg of folic acid reference substance, place it in a 500-mL volumetric flask, add a small amount of water and 10 μL of ammonia water, dissolve it by ultrasonication, add water to make up to volume, mix well, and the stock standard solution of folic acid (21.46 μg / mL) is obtained.

[0100] Accurately weigh 5.14 mg of homocysteine ​​reference substance, place it in an injection vial, add about 10 mg of dithiothreitol, accurately add 1 mL of water, ultrasonically dissolve, mix well, and obtain the homocysteine ​​stock standard solution (5.14 mg / mL).

[0101] Accurately pipette 20 μL of the stock standard solution of folic acid and 40 μL of the stock standard solution of homocysteine ​​into a 50 mL volumetric flask, add water to make up to volume, and shake well to obtain the intermediate standard solutions of folic acid and homocysteine ​​(8.58 ng / mL and 4112 ng / mL).

[0102] Accurately pipette appropriate amounts of intermediate standard solution into injection vials, add extraction reagent, add working standard solution of folic acid isotope internal standard, add working standard solution of homocysteine-D8 isotope internal standard, mix well, and obtain working standard solution, as shown in the table below. Working standard solution of appropriate concentration can be prepared according to instrument response and actual conditions.

[0103]

[0104] 3.3 Drawing of standard working curve

[0105] Accurately pipette 10 μL of the working standard solution and inject it into the liquid chromatography-mass spectrometer to establish the standard curve equation of the internal standard method.

[0106] 3.4 Preparation of test samples

[0107] Accurately pipette 20 μL of blood and drop it on the fixed spot range of the card, dry it in the dark for about 3 hours to make a dry blood spot card. Cut off 2 spots on the dry blood spot card sample with scissors (equivalent to 40 μL of blood), put it into a 30kDa centrifugal filter device (Amicon Ultra-0.5), accurately add 200 μL of extraction solution containing isotope internal standard, vortex extract for about 30 seconds, stand in the dark for 15 minutes, then vortex mix for about 30 seconds, then gradually increase the speed to 1000r / min, 2000r / min, 4000r / min, 10000r / min, centrifuge for 2 minutes at each speed, and obtain the sample solution. Accurately pipette 10 μL of the sample solution and inject it into the liquid chromatography-mass spectrometer to determine the content of folic acid and homocysteine.

[0108] 3.5 Calculation results:

[0109] The folate and homocysteine ​​levels in the blood were directly determined using the standard curve equation that included the sample dilution multiple.

[0110] Alternatively, the folic acid and homocysteine ​​levels in the blood can be calculated using the following formula using the standard curve equation that does not include the sample dilution multiple:

[0111]

[0112] Where:

[0113] X—the content of folic acid (homocysteine) in the sample, ng / mL;

[0114] C—concentration of folic acid (homocysteine) in the sample solution, ng / mL;

[0115] M—volume of sample, μL;

[0116] V—volume of sample dilution, μL;

[0117] K—unit conversion coefficient, K=1.

[0118] 4. Methodological Validation

[0119] 4.1 Method optimization experiment

[0120] 4.1.1 Optimization of extraction reagent purification

[0121] The matrix of whole blood samples is more complex than that of plasma and serum. Folic acid needs to go through a purification step to be accurately detected. Therefore, the purification step is particularly critical. According to the extraction step of the prior art (patent number 202110609367.3), the whole blood sample is treated with a mixture of 5% isopropanol and 20% trichloroacetic acid containing 0.1 mol / L hydrochloric acid and 15 μg / mL dithiothreitol, and the chromatogram of the extraction reagent treated with the extraction step of the present invention is compared. The chromatogram of the whole blood sample of the literature method is as follows: Figure 1 The chromatogram of the whole blood sample of the present invention is as follows Figure 2 The chromatogram of the whole blood sample in the prior art has serious matrix interference, and folic acid cannot be accurately quantified. However, after the purification step, the present invention has no matrix interference, and folic acid can be accurately quantified.

[0122] 4.1.2 Optimization of Hcy stabilizer in extraction reagent

[0123] The matrix of whole blood samples is more complex than that of plasma and serum. The stability of Hcy in the extraction reagent is very poor. In a short period of time, most of the Hcy has been degraded, which seriously affects the accuracy of the test results. It is necessary to develop a stabilizer with an appropriate concentration.

[0124] According to the prior art method, 15 μg / mL dithiothreitol (DTT) cannot stabilize the Hcy in the whole blood sample extraction reagent. The present invention tests different concentrations of DTT, and after the extraction reagent is placed at room temperature, the peak area of ​​Hcy is measured.

[0125]

[0126] According to the above table, the preferred DTT concentration of 43 mg / mL in the present invention is the most stable for the Hcy of the whole blood sample extraction reagent.

[0127] 4.1.3 Optimization of centrifugal filter device and centrifugal speed

[0128] Centrifugal filter devices for ultrafiltration have different cutoff specifications, and selecting the appropriate cutoff specification is particularly important for the purification effect of the sample. The present invention tests the centrifugal filter device for ultrafiltration with a cutoff specification of 3-100kDa. The matrix of whole blood samples is complex, and the filtrate is difficult to pass through the 3kDa and 10kDa centrifugal filter devices, and the yield of the filtrate is low; the 50kDa and 100kDa centrifugal filter devices have poor purification effects on the filtrate.

[0129] The rotation speed of the centrifugal filter device also has a great influence on the purification effect of the filtrate. The present invention has tested a centrifugal speed of 1000-10000 r / min. The matrix of whole blood samples is complex, and the yield of the filtrate is low at a rotation speed of 1000-4000 r / min; at a rotation speed of 5000-10000 r / min, the ultrafiltration membrane of the centrifugal filter device will break, resulting in purification failure.

[0130] The peak area of ​​folic acid was determined using extraction reagents obtained using different centrifugal devices and different centrifugal speeds.

[0131]

[0132] According to the above table, the present invention preferably selects a 30kDa centrifugal filter device, taking into account both the filtrate yield and the filtrate purification effect; the present invention preferably increases the rotation speed gradually to 1000r / min, 2000r / min, 4000r / min, and 10000r / min, solving the problems of low filtrate yield and ultrafiltration membrane damage.

[0133] 4.1.4 Optimization of extraction reagent composition

[0134] The selection of the components of the extraction reagent has a great influence on the extraction efficiency of folic acid and Hcy and the stability of the extraction reagent. Therefore, it is particularly important to select a suitable extraction reagent. The present invention tests the ratio of reagents such as ascorbic acid, BHT, citric acid, trichloroacetic acid, ammonia water, sodium carbonate, dithiothreitol, and mercaptoethanol.

[0135] The peak areas of folic acid and Hcy were determined using extraction reagents obtained with different component ratios.

[0136]

[0137] According to the above table, the present invention preferably selects ascorbic acid, citric acid, ammonia water, and dithiothreitol, taking into account the yields of folic acid and Hcy, and the extraction reagent has good stability.

[0138] 4.2 Specificity test (blank)

[0139] 4.2.1 Test methods

[0140] Without adding sample, treat blank according to the sample preparation method in 3.4, measure blank according to the conditions in 3.1, and compare the peak time with that of folic acid and homocysteine ​​working standard solutions.

[0141] 4.2.2 Test results

[0142] See Figure 3-6 . Figure 3 is the blank chromatogram of folic acid; Figure 4 is the blank chromatogram of homocysteine; Figure 5 is the control chromatogram of folic acid; Figure 6 The homocysteine ​​control chromatogram is shown in Figure 2 .

[0143] 4.2.3 Test conclusion:

[0144] The blank had no peaks at the peak times of folic acid and homocysteine, indicating that the blank had little interference with the determination results.

[0145] 4.3 Confirmation of linear range

[0146] 4.3.1 Standard working curve

[0147] Draw the internal standard working curve as shown in Figure 7-8 shown.

[0148] 4.3.2 Conclusion of linear test

[0149] Linear evaluation: The correlation coefficients R of folic acid and homocysteine ​​were 0.99941 and 0.99974, respectively. Therefore, this method showed good linearity in the determination of folic acid and homocysteine.

[0150] 4.4 Limit of detection and limit of quantification

[0151] The detection limit DL and quantification limit QL of the analytical method were calculated by the signal-to-noise ratio (S / N). DL was defined as the concentration of the analyte corresponding to S / N = 3, and QL was defined as the concentration of the analyte corresponding to S / N = 10. The results are shown in Figure 9-10 The detection limit of folic acid in dried blood spots is 0.17 ng / mL, and the quantification limit is 0.53 ng / mL.

[0152] Homocysteine ​​in dried blood spots: detection limit: 9.5 ng / mL, quantification limit: 29 ng / mL.

[0153] 4.5 Precision test

[0154] 4.5.1 Test methods

[0155] Take 12 samples, process them according to the sample preparation method in 3.4, determine the folic acid and homocysteine ​​contents in the samples, and calculate their RSD (%).

[0156] 4.5.2 Test data (see the table below) [Test sample: dried blood spots]

[0157]

[0158] 4.5.3 Test conclusion

[0159] The intra-day RSDs of folic acid and homocysteine ​​in the samples were 7.2% and 1.1%, and the inter-day RSDs were 5.2% and 3.5%, respectively, indicating that the method had good precision.

[0160] 4.6 Durability test (stability)

[0161] 4.6.1 Dried blood spot card stability test:

[0162] 4.6.1.1 Test method:

[0163] Process the samples according to the sample preparation method in 5.4. Place the dried blood spot cards in aluminum foil bags and seal them. Place them at room temperature, 4°C, and -20°C for 0 days, 3 days, 6 days, and 20 days, respectively. Detect the sample content according to the conditions in 3.1 and draw a content trend graph.

[0164] 4.5.1.2 Test data:

[0165]

[0166] 4.6.1.3 Test conclusion

[0167] After the dried blood spot cards were placed at room temperature, 4°C, and -20°C for 0 days, 5 days, 10 days, and 20 days, respectively, the folic acid and homocysteine ​​contents in the dried blood spot cards were stable, indicating that the folic acid and homocysteine ​​in the dried blood spot cards were stable within 20 days at room temperature, 4°C, and -20°C.

[0168] 4.6.2 Sample solution stability test:

[0169] 4.6.2.1 Test method:

[0170] After the folic acid and homocysteine ​​test solutions were placed at room temperature for 0 h, 1 h, 2 h, 4 h, 6 h, and 8 h, the concentrations were determined according to the conditions in 5.1 and their RSD (%) were calculated.

[0171] 4.6.2.2 Test data:

[0172]

[0173] 4.6.2.3 Test conclusion

[0174] After the folic acid and homocysteine ​​test solutions were placed at room temperature for 0h, 1h, 2h, 4h, 6h, and 8h, respectively, the RSDs of the folic acid and homocysteine ​​concentrations were 5.9% and 1.3%, indicating that the folic acid and homocysteine ​​test solutions had good stability within 8 hours at room temperature.

[0175] 4.7 Accuracy test (recovery rate)

[0176] 4.7.1 Test methods

[0177] Spike addition: Accurately pipette an appropriate amount of blood samples into 9 portions, and accurately add folic acid and homocysteine ​​standard solutions respectively. Treat the samples according to the sample preparation method in 3.4.

[0178] 4.7.2 The test data are as follows [Test sample: dried blood spots]

[0179] Recovery test results table

[0180]

[0181]

[0182] Recovery rate (%) = (measured value - background value) / spiked value × 100%.

[0183] 4.7.3 Test conclusion

[0184] The average recoveries of folic acid and homocysteine ​​were 92.3% and 100.9%, respectively, and the RSDs were 6.3% and 3.0%, respectively, indicating that the method had a good recovery rate and good accuracy.

[0185] Comparative Example 1 Comparative test between the literature method and the method of the present invention for dried blood spot determination (DBS-LC-MS)

[0186] 1. Literature Method

[0187] Literature detection method for homocysteine: Use a hole puncher to take 2 pieces of DBS samples with a diameter of 3mm into a 96-well deep-well plate, add 20μL of 3.7μmol / L homocystine-D8 internal standard working solution and 20μL of 500mmol / L reducing agent (DTT), shake for 2min, and let stand at room temperature for 15min. After the disulfide bond of homocystine-D8 is reduced by DTT, it becomes a monomeric deuterated homocysteine ​​Hcy-D4. Add 400μL of extractant (containing 0.1% FA and 0.05% TFA in acetonitrile solution by volume fraction), shake for 2min, centrifuge at 4000r / min for 5min, and draw 70μL of supernatant into a 96-well sample plate, and detect by LC-MS / MS.

[0188] Folic acid literature detection method: 100μL of blood sample to be tested + 20μL internal standard (10ng / mL) + 300μL solvent A, vortex shake for 2 minutes. Oasis MAXμElution SPE process: Extract the pretreated standard or plasma sample according to the protocol, blow dry the eluate directly on the positive pressure device of SPE for about 15 minutes, then re-dissolve it with 80μL solvent B (containing 100μg / mL each of ascorbic acid, citric acid and mercaptoethanol, plus 2% formic acid), then shake it on a 96-well plate constant temperature shaker for 1 minute before LC-MS / MS analysis.

[0189] 2. Comparative test results

[0190] name Homocysteine Folic acid unit ng / mL ng / mL Literature Methods 522.8 0.9509 Method of the present invention 510.3 0.9456 Relative deviation % 2.5 0.6

[0191] 3. Test conclusion

[0192] By comparing the methods in the literature and the DBS-LC-MS method of the present invention for determining the contents of folic acid and homocysteine ​​in blood, the relative deviation of the results of the two methods was less than 5%, proving that the method for determining folic acid and homocysteine ​​in blood by dried blood spots has good accuracy.

Claims

1. A method for simultaneously determining the content of folic acid and homocysteine ​​in blood, characterized in that: Place the dried blood spot blood sample into a 30kDa centrifugal filter device, add the extraction reagent, vortex extract for about 30 seconds, keep it away from light for 15 minutes, then vortex mix for about 30 seconds, then gradually increase the speed to 1000r / min, 2000r / min, 4000r / min, and 10000r / min, and centrifuge for 2 minutes at each speed to obtain the extract; The extract was analyzed by high performance liquid chromatography-mass spectrometry and quantified by internal standard method; the chromatographic conditions of high performance liquid chromatography in the analysis were as follows: chromatographic column: Waters, HSS T3, 100×2.1 mm, 2.5 μm; Column temperature: 40°C; injection volume: 10 μL; flow rate: 0.25 mL / min; mobile phase: A is 0.1% formic acid aqueous solution, B is 0.1% formic acid acetonitrile solution, gradient elution, the gradient elution conditions are as follows: The extraction reagent preparation steps are as follows: weigh 10 mg of ascorbic acid and 10 mg of citric acid, add 9.5 mL of water and 0.5 mL of ammonia water, dissolve and mix, transfer 0.22 mL, add 4.78 mL of water, add 215 mg of dithiothreitol, dissolve and mix, and obtain the extraction reagent.

Citation Information

Patent Citations

  • Method and kit for simultaneously detecting various metabolites on homocysteine metabolic pathway and application of method and kit

    CN113341012A

  • Analysis of total homocysteine and methylmalonic acid in plasma by LC-MS / MS from a plasma separator device (PSD)

    CN103748469A

  • Strong interference resistant homocysteine detection kit

    CN104111337A

  • Kit for detecting activity of MTHFR (5,10-methylene tetrahydrofolate reductase)

    CN106434847A

  • Method for detecting contents of folic acid and sulfur-containing amino acid in plasma

    CN106442836A